Thomas Lieber
's-hertogenbosch, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women.
Journal: Frontiers in drug safety and regulation
Published: August 20, 2025
Comparison of Perceived Adverse Events After COVID-19 Vaccination Between Pregnant and NonPregnant Women Using Two Cohort Studies in the Netherlands.
Journal: Birth defects research
Published: November 21, 2024
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study.
Journal: Drug safety
Published: May 26, 2024
GP consultations for menstrual disorders after COVID-19 vaccination - A self-controlled cohort study based on routine healthcare data from the Netherlands.
Journal: Vaccine
Published: March 11, 2024
The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands.
Journal: Expert opinion on drug safety
Published: October 05, 2023
The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands.
Journal: Drug safety
Published: September 20, 2023
Natural language processing for automated triage and prioritization of individual case safety reports for case-by-case assessment.
Journal: Frontiers in drug safety and regulation
Published: December 09, 2022
Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.
Journal: Frontiers in immunology
Published: October 24, 2022
Last Updated: 09/26/2026